Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta cir. bras ; 31(11): 730-735, Nov. 2016. tab, graf
Article Dans Anglais | LILACS | ID: biblio-827659

Résumé

ABSTRACT PURPOSE: To assess and compare the histopathological effects of ozone therapy and/or methylprednisolone (MPS) treatment on regeneration after crush type sciatic nerve injury. METHODS: Forty Sprague-Dawley male rats were randomly allocated into four groups. Four groups received the following regimens intraperitoneally every day for 14 days after formation of crush type injury on sciatic nerve: Group I: ozone (20mcg/ml); Group II: methylprednisolone (2mg/kg); Group III: ozone (20 mcg/ml) and methylprednisolone (2mg/kg); Group IV: isotonic saline (0.9%). The histomorphological evaluation was made after biopsies were obtained from the sites of injury. RESULTS: Significant differences were noted between groups in terms of degeneration (p=0.019), nerve sheath cell atrophy (p=0.012), intraneural inflammatory cellular infiltration (p=0.002), perineural granulation tissue formation (p=0.019), perineural vascular proliferation (p=0.004), perineural inflammatory cellular infiltration (p<0.001) and inflammation in peripheral tissue (p=0.006). Degeneration was remarkably low in Group III, while no change in nerve sheath cell was noted in Group II. CONCLUSION: The combined use of methylprednisolone and ozone treatment can have beneficial effects for regeneration after crush type nerve injury.


Sujets)
Animaux , Mâle , Rats , Oxydants photochimiques/usage thérapeutique , Ozone/usage thérapeutique , Nerf ischiatique/traumatismes , Méthylprednisolone/usage thérapeutique , Lésions des nerfs périphériques/traitement médicamenteux , Régénération nerveuse/effets des médicaments et des substances chimiques , Oxydants photochimiques/administration et posologie , Ozone/administration et posologie , Nerf ischiatique/effets des médicaments et des substances chimiques , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Méthylprednisolone/administration et posologie , Répartition aléatoire , Rat Sprague-Dawley , Récupération fonctionnelle/effets des médicaments et des substances chimiques , Lésions des nerfs périphériques/physiopathologie , Inflammation , Écrasement de nerf
2.
Rev. méd. Chile ; 139(4): 439-447, abr. 2011. ilus
Article Dans Espagnol | LILACS | ID: lil-597638

Résumé

Background: Ozone therapy may stimulate antioxidant systems and protect against free radicals. It has not been used formerly in patients with pulmonary emphysema. Aim: To assess the effects of rectal ozone therapy in patients with pul-monary emphysema. Material and Methods: Sixty four patients with pulmonary emphysema, aged between 40 and 69 years, were randomly assigned to receive rectal ozone in 20 daily sessions, rectal medicinal oxygen or no treatment. Treatments were repeated three months later in the frst two groups. At baseline and at the end of the study, spirometry and a clinical assessment were performed. Results: fifty patients completed the protocol, 20 receiving ozone therapy, 20 receiving rectal oxygen and 10 not receiving any therapy. At baseline, patients on ozone therapy had significantly lower values of forced expiratory volume in the frst second (fEV1) and fEV1/forced vital capacity. At the end of the treatment period, these parameters were similar in the three treatment groups, therefore they only improved significantly in the group on ozone therapy. No differences were observed in other spirometric parameters. Conclusions: Rectal ozone therapy may be useful in patients with pulmonary emphysema.


Sujets)
Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Oxydants photochimiques/administration et posologie , Oxygène/administration et posologie , Ozone/administration et posologie , Emphysème pulmonaire/thérapie , Administration par voie rectale , Méthode en double aveugle , Emphysème pulmonaire/physiopathologie , Tests de la fonction respiratoire , Indice de gravité de la maladie , Résultat thérapeutique
3.
Article Dans Anglais | IMSEAR | ID: sea-139878

Résumé

Background: The development of periodontal disease has been thought to be associated with several restricted members of the oral anaerobic species, such as black-pigmented Porphyromonas species and Actinobacillus actinomycetemcomitans (Aa), in the subgingival environment. Apart from bacteria, certain viruses and fungi that are associated with periodontal disease are also present in the subgingival plaque . Materials and Methods: A randomized, double-blind, crossover split-mouth design was performed. A total of 16 patients suffering from generalized chronic periodontitis were selected for the study. The study period of 18 days was divided into two time-intervals, i.e. baseline (0 days) to 7 th day, with a washout period of 4 days followed by a second time interval of 7 days. The use of ozone and chlorhexidine gluconate (CHX) irrigation was randomized. Both the patient and the clinician evaluating the clinical parameters were blinded regarding the type of irrigation used. Results: The interpretation of clinical and microbial data is from baseline to 7 th day. A higher percentage of plaque index (12%), gingival index (29%) and bleeding index (26%) reduction was observed using ozone irrigation as compared to chlorhexidine. The percentile reduction of Aa (25%) using ozone was appreciable as compared to no change in Aa occurrence using chlorhexidine. By using O 3 and chlorhexidine, there was no antibacterial effect on Porphyromonas gingivalis (Pg) and Tannerella forsythensis. The antifungal effect of ozone from baseline (37%) to 7 th day (12.5%) was pronounced during the study period, unlike CHX, which did not demonstrate any antifungal effect. Conclusion: Ozone may be considered as an alternative management strategy due to its powerful ability to inactivate microorganisms. Also, there is growing evidence that ozone can be employed as a useful therapeutic agent in both dentistry and medicine.


Sujets)
Aggregatibacter actinomycetemcomitans/effets des médicaments et des substances chimiques , Parodontite agressive/traitement médicamenteux , Anti-infectieux locaux/administration et posologie , Anti-infectieux locaux/usage thérapeutique , Antifongiques/administration et posologie , Antifongiques/usage thérapeutique , Antiviraux/administration et posologie , Antiviraux/usage thérapeutique , Bacteroides/effets des médicaments et des substances chimiques , Candida albicans/effets des médicaments et des substances chimiques , Chlorhexidine/administration et posologie , Chlorhexidine/usage thérapeutique , Parodontite chronique/traitement médicamenteux , Études croisées , Cytomegalovirus/effets des médicaments et des substances chimiques , Indice de plaque dentaire , Méthode en double aveugle , Hémorragie gingivale/traitement médicamenteux , Herpèsvirus humain de type 1/effets des médicaments et des substances chimiques , Herpèsvirus humain de type 2/effets des médicaments et des substances chimiques , Herpèsvirus humain de type 4/effets des médicaments et des substances chimiques , Humains , Oxydants photochimiques/administration et posologie , Oxydants photochimiques/usage thérapeutique , Ozone/administration et posologie , Ozone/usage thérapeutique , Indice parodontal , Porphyromonas gingivalis/effets des médicaments et des substances chimiques , Irrigation thérapeutique , Facteurs temps , Facteurs temps
SÉLECTION CITATIONS
Détails de la recherche